Previous terms
continue: Approved consistent with the understanding that GenICs
under this generic will be limited to acute public health
emergencies resulting from outbreaks or events with undetermined
agent, source, mode of transmission, or risk factors. Data
collection for investigations conducted under this generic will not
exceed 90 days. Investigations conducted for the primary purpose of
program evaluation, surveillance, needs assessment, or research
(e.g., to contribute to generalizable knowledge) are excluded from
this generic pathway.
Inventory as of this Action
Requested
Previously Approved
01/31/2023
01/31/2023
01/31/2023
947,000
0
36,000
473,500
0
473,500
0
0
0
The purpose of this non-substantive
change request is for OMB approval for an increase in the number of
respondents for this EEI generic ICR, which is necessary to ensure
CDC’s ability to respond to the COVID-19 pandemic.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.